Stockscreener 앱 받기
3.25
6.21%
0.19
시간 외 거래:
3.29
0.04
+1.23%
전일 마감가:
$3.06
열려 있는:
$3.03
하루 거래량:
275.59K
Relative Volume:
0.98
시가총액:
$411.33M
수익:
-
순이익/손실:
$-59.00M
주가수익비율:
-6.9548
EPS:
-0.4673
순현금흐름:
$-51.97M
1주 성능:
+3.83%
1개월 성능:
+39.48%
6개월 성능:
+195.45%
1년 성능:
+322.02%
1일 변동 폭
$3.03
$3.275
1주일 범위
$2.83
$3.275
52주 변동 폭
$0.62
$4.3101
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
명칭
Nautilus Biotechnology Inc
전화
206-333-2001
주소
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
3.25 | 387.29M | 0 | -59.00M | -51.97M | -0.4673 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2022-01-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-11-02 | 개시 | Cowen | Outperform |
| 2021-08-04 | 개시 | Goldman | Neutral |
| 2021-07-13 | 개시 | Jefferies | Buy |
모두보기
Nautilus Biotechnology Inc 주식(NAUT)의 최신 뉴스
Nautilus Biotechnology (NAUT) price target increased by 60.00% to 4.08 - MSN
Here is why Nautilus Biotechnology (NAUT) is one of the best life sciences penny stocks to buy - MSN
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy - Insider Monkey
How does Nautilus Biotechnology Inc compare to its peersProduct Launch & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Published on: 2026-04-11 15:42:56 - baoquankhu1.vn
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 - Investing News Network
NAUT PE Ratio & Valuation, Is NAUT Overvalued - Intellectia AI
NAUT Technical Analysis & Stock Price Forecast - Intellectia AI
Published on: 2026-03-31 08:20:41 - baoquankhu1.vn
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - Sahm
Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements - Traders Union
Nautilus Biotechnology at Investor Summit: Innovative Proteomics Pathway By Investing.com - Investing.com India
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year - marketbeat.com
Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week HighWhat's Next? - MarketBeat
Aug Chart Watch: Is Nautilus Biotechnology Inc forming a breakout patternTrade Entry Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - bitget.com
Nautilus management presents online March 25; webcast stays available - Stock Titan
Technical Analysis: Is Nautilus Biotechnology Inc stock a smart retirement pick2026 Earnings & Comprehensive Market Scan Insights - baoquankhu1.vn
If You Invested $1,000 in Nautilus Biotechnology Inc (NAUT) - Stock Titan
Published on: 2026-03-21 20:59:37 - baoquankhu1.vn
Baylor College of Medicine initiates research with Nautilus Biotechnology Voyager Platform - Traders Union
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform - Bitget
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program ... - Bluefield Daily Telegraph
Nautilus Biotechnology Announces Baylor College of Medicine - GlobeNewswire
What’s the MACD signal for Nautilus Biotechnology Inc.July 2025 Chart Watch & High Win Rate Trade Tips - mfd.ru
Aug Sectors: Is Nautilus Biotechnology Inc forming a breakout patternWeekly Investment Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Nautilus names Amber Faust VP of sales - The Pharma Letter
Sujal Patel Buys 25,000 Shares of Nautilus Biotechnology (NASDAQ:NAUT) Stock - MarketBeat
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Executive Parag Mallick receives 280,000 stock options at Nautilus (NAUT) - Stock Titan
Nautilus (NAUT) CEO Sujal Patel receives 650,000 stock option award - Stock Titan
Nautilus Biotechnology (NAUT) Chief People Officer granted 160,000 options - Stock Titan
Nautilus (NAUT) General Counsel receives 160,000-share stock option grant - Stock Titan
Nautilus Biotechnology appoints Amber Faust as VP of sales By Investing.com - Investing.com Canada
Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion - Traders Union
NAUT: New proteomics platform promises comprehensive, reproducible protein analysis with broad applications - TradingView
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - BioSpace
Nautilus Biotechnology appoints proteomics commercial leader Amber Faust as vice president of sales - marketscreener.com
Nautilus Biotechnology appoints Amber Faust as VP of sales - Investing.com
Sales veteran joins Nautilus to push single-molecule proteomics into labs - Stock Titan
Guggenheim Forecasts Strong Price Appreciation for Nautilus Biotechnology (NASDAQ:NAUT) Stock - Defense World
Aug Big Picture: What are PROFs growth levers2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
NAUT Should I Buy - Intellectia AI
Nautilus Biotechnology (NAUT) Target Price Raised by Guggenheim - GuruFocus
Nautilus debuts Voyager platform in push toward next-gen proteomics - Longevity.Technology
Nautilus Biotechnology (NASDAQ:NAUT) Price Target Raised to $4.00 at Guggenheim - MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology stock price target raised to $4 by Guggenheim - Investing.com Canada
Nautilus (NAUT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nautilus Biotechnology Q4 Earnings Call Highlights - MarketBeat
Nautilus Biotechnology Inc (NAUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):